Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS - Concepedia

Concepedia

Publication | Open Access

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

DOI Full Paper Access

31

Citations

18

References

2021

Year

Jens Kühle, Nadia Daizadeh, Pascal Benkert, Aleksandra Maleska Maceski, Christian Barro, Zuzanna Michalak, Maria Pia Sormani, J.F. GODIN, Srinivas Shankara, Tarek A. Samad,

Multiple Sclerosis Journal

Abstract

NCT00530348, NCT00930553, NCT02255656.

References

	Year	Citations

Page 1